1. X
  2. Medable
Log inSign up
Medable
5,204 posts
Image
user avatar
Medable
@medableinc
Removing the bottleneck in curing disease with agentic AI.
Palo Alto
medable.com
Joined February 2013
1,027
Following
3,650
Followers
RepliesRepliesMediaMedia
  • Pinned
    user avatar
    Medable
    @medableinc
    Mar 2
    Did you know that manual document reconciliation between trial systems consumes at least one-third of clinical data managers' and clinical research associates’ time? This means your highly trained professionals are spending their days chasing files between platforms rather than
    Image
    00:00
  • user avatar
    Medable
    @medableinc
    Aug 5
    What makes Medable different? For Asad Khan, it's our commitment to putting patients first, a culture built on collaboration, and a belief that success should create a positive impact beyond the workplace. 💯 Hear more below about what makes him proud to be part of the team. 🙌
    Image
    00:00
  • user avatar
    Medable
    @medableinc
    Aug 5
    Funding pressure, the patent cliff, smaller sponsors, and rising AI expectations are all converging at the same time. Together, they're forcing CROs to rethink a commercial model that has barely changed in decades. The next generation of market leaders won't simply automate more
    Image
  • user avatar
    Medable
    @medableinc
    Aug 4
    Your study teams shouldn't have to work harder because your systems don't work together. 💯 Yet every day, they lose valuable time jumping between applications, reconciling information, and chasing updates. Agent Studio connects the clinical and enterprise technology you
    Image
    00:00
  • user avatar
    Medable
    @medableinc
    Jul 31
    Every day a clinical trial runs inefficiently is another day patients wait longer for the answers they deserve. That's what drives everything we do at Medable, and it's why we've embedded AI into the heart of clinical trial operations to accelerate drug development. We're proud
    Image

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Advertisement
Advertisement